Biotage AB (publ)

BITGF · OTC
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income$328,000$303,000$348,000$269,000
Dep. & Amort.$185,000$149,000$101,000$75,000
Deferred Tax$0$0$0$0
Stock-Based Comp.$1,000$3,000$0$0
Change in WC$44,000-$86,000-$39,000$21,000
Other Non-Cash-$145,000-$85,000-$69,000-$12,000
Operating Cash Flow$413,000$284,000$341,000$353,000
Investing Activities
PP&E Inv.-$89,000-$26,000-$35,000-$23,000
Net Acquisitions-$287,000$125,000-$12,000-$282,000
Inv. Purchases$0$0-$2,000-$2,000
Inv. Sales/Matur.$0$1,000$0$0
Other Inv. Act.-$80,000-$65,000-$35,000-$34,000
Investing Cash Flow-$456,000$35,000-$84,000-$341,000
Financing Activities
Debt Repay.-$30,000-$38,000-$30,000$16,000
Stock Issued$2,000$2,000$0$0
Stock Repurch.$0$0$0$0
Dividends Paid-$128,000-$106,000-$102,000-$98,000
Other Fin. Act.$0$0-$1,000$0
Financing Cash Flow-$156,000-$142,000-$133,000-$82,000
Forex Effect$39,000-$24,000$6,000$9,000
Net Chg. in Cash-$160,000$153,000$130,000-$60,000
Supplemental Information
Beg. Cash$594,000$441,000$311,000$371,000
End Cash$434,000$594,000$441,000$311,000
Free Cash Flow$244,000$193,000$271,000$297,000